Italy. The Italian government has increased from 5% to 5.5% the duty – payable by 30 April 2012 – that it imposes annually on the amount spent by medical technology firms on "promotional activities." The duty applies to the sum of a whole range of costs, including advertising, trade shows, personnel training, outsourcing and the cost of the samples and display devices, for example.
All medical device and in vitro diagnostic (IVD) firms operating in Italy as either producers or suppliers are affected. Source: Clinica
Austria has introduced a new medical device tax payable in June 2012 for the year 2011.The tax will be levied according to the risk of the device. Taxes will be 250 Euros for Class I devices, increasing by 50 Euros for each subsequent class of devices. This will mean that for Class III devices will be taxed at a rate of 400 Euros. In each case the total amount charged will be to a maximum of 2000 Euros in total. For companies supplying different classes of medical device – the tax will be levied on the highest risk product. Source: Clinica
United States has proposed a regulation, which is awaiting comments by 7 May 2012. This regulation provides guidance on the 2.3%excise tax that will be imposed on the sale of certain medical devices by a manufacturer, producer, or importer. The excise tax was added to the U.S. Internal Revenue Code as part of the Health Care and Education Reconciliation Act of 2010, in conjunction with the Patient Protection and Affordable Care Act.
For more information click here